CStone Pharmaceuticals Dividends and Buybacks
Dividend criteria checks 0/6
CStone Pharmaceuticals does not have a record of paying a dividend.
Key information
n/a
Dividend yield
-0.01%
Buyback Yield
| Total Shareholder Yield | -0.01% |
| Future Dividend Yield | 0% |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
There's No Escaping CStone Pharmaceuticals' (HKG:2616) Muted Revenues Despite A 29% Share Price Rise
Oct 04
Improved Revenues Required Before CStone Pharmaceuticals (HKG:2616) Stock's 27% Jump Looks Justified
May 12Lacklustre Performance Is Driving CStone Pharmaceuticals' (HKG:2616) 28% Price Drop
Mar 04Benign Growth For CStone Pharmaceuticals (HKG:2616) Underpins Stock's 25% Plummet
Jan 18The Market Doesn't Like What It Sees From CStone Pharmaceuticals' (HKG:2616) Revenues Yet As Shares Tumble 26%
Oct 04Is CStone Pharmaceuticals (HKG:2616) A Risky Investment?
Oct 03Is CStone Pharmaceuticals (HKG:2616) A Risky Investment?
Oct 20Is CStone Pharmaceuticals (HKG:2616) Using Too Much Debt?
Dec 17Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if 2616's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 2616's dividend payments have been increasing.
Dividend Yield vs Market
| CStone Pharmaceuticals Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (2616) | n/a |
| Market Bottom 25% (HK) | 3.3% |
| Market Top 25% (HK) | 8.1% |
| Industry Average (Biotechs) | 1.1% |
| Analyst forecast (2616) (up to 3 years) | 0% |
Notable Dividend: Unable to evaluate 2616's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate 2616's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate 2616's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as 2616 has not reported any payouts.